Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G/A
Neogen Corp
Feb 17, 2026
[Form 4] NEOGEN CORP Insider Trading Activity
Feb 2, 2026
[Form 4] NEOGEN CORP Insider Trading Activity
Jan 26, 2026
[Form 4] NEOGEN CORP Insider Trading Activity
2.44B
215.48M
Diagnostics & Research
In Vitro & in Vivo Diagnostic Substances
United States
LANSING